Literature DB >> 12716740

A new murine model of islet xenograft rejection: graft destruction is dependent on a major histocompatibility-specific interaction between T-cells and macrophages.

Peter Schmidt1, Henrik Krook, Akira Maeda, Olle Korsgren, Birgitta Benda.   

Abstract

A new murine model of porcine islet-like cell cluster (ICC) xenograft rejection, avoiding interference of unspecific inflammation, was introduced and used to investigate rejection mechanisms. Athymic (nu/nu) mice were transplanted with syngeneic, allogeneic, or xenogeneic islets under the kidney capsule. After the original transplantation, immune cells in porcine ICC xenografts undergoing rejection in native immunocompetent mice were transferred to the peritoneal cavity of the athymic mice. At defined time points after transfer, the primary grafts were evaluated by immunohistochemistry and real-time quantitative RT-PCR to estimate cytokine and chemokine mRNA expression. Transfer of immunocompetent cells enabled athymic (nu/nu) mice to reject a previously tolerated ICC xenograft only when donor and recipient were matched for major histocompatibility complex (MHC). In contrast, allogeneic and syngeneic islets were not rejected. The ICC xenograft rejection was mediated by transferred T-cells. The main effector cells, macrophages, were shown to be part of a specific immune response. By day 4 after transplantation, there was an upreglation of both Th1- and Th2-associated cytokine transcripts. The transferred T-cells were xenospecific and required MHC compatibility to induce rejection. Interaction between the TCR of transferred T-cells and MHC on host endothelial cells and/or macrophages seems necessary for inducing ICC xenograft rejection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716740     DOI: 10.2337/diabetes.52.5.1111

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  8 in total

1.  A new method for incorporating functional heparin onto the surface of islets of Langerhans.

Authors:  Sanja Cabric; Torsten Eich; Javier Sanchez; Bo Nilsson; Olle Korsgren; Rolf Larsson
Journal:  Tissue Eng Part C Methods       Date:  2008-06       Impact factor: 3.056

Review 2.  Transplantation of xenogeneic islets: are we there yet?

Authors:  Philip J O'Connell; Peter J Cowan; Wayne J Hawthorne; Shounan Yi; Andrew M Lew
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

3.  CD4 T cells mediate cardiac xenograft rejection via host MHC Class II.

Authors:  Robert J Plenter; Todd J Grazia; An N Doan; Ronald G Gill; Biagio A Pietra
Journal:  J Heart Lung Transplant       Date:  2012-07-11       Impact factor: 10.247

Review 4.  Pancreatic islet xenotransplantation: barriers and prospects.

Authors:  Gina R Rayat; Ronald G Gill
Journal:  Curr Diab Rep       Date:  2003-08       Impact factor: 4.810

5.  Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes.

Authors:  Charles Sia; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-02-10

Review 6.  Xenotransplantation: immunological hurdles and progress toward tolerance.

Authors:  Adam Griesemer; Kazuhiko Yamada; Megan Sykes
Journal:  Immunol Rev       Date:  2014-03       Impact factor: 12.988

7.  Adoptive transfer with in vitro expanded human regulatory T cells protects against porcine islet xenograft rejection via interleukin-10 in humanized mice.

Authors:  Shounan Yi; Ming Ji; Jingjing Wu; Xiaoqian Ma; Peta Phillips; Wayne J Hawthorne; Philip J O'Connell
Journal:  Diabetes       Date:  2012-03-08       Impact factor: 9.461

8.  Engineering a Tumor Microenvironment-Mimetic Niche for Tissue Regeneration with Xenogeneic Cancer Cells.

Authors:  Zhenzhen Wang; Chunming Wang; Ayipaxia Abudukeremu; Xiaying Rui; Shang Liu; Xiaoyi Zhang; Min Zhang; Junfeng Zhang; Lei Dong
Journal:  Adv Sci (Weinh)       Date:  2018-01-02       Impact factor: 16.806

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.